← Back to patent-cliff list
CAS 1453-82-3
Isonicotinamide
Codes: Isoniazid-014
Application context (from source-drug indications)
Mycobacterium tuberculosis infectionEthambutol Hydrochloride/Rifampicin/IsoniazidPulmonary tuberculosisIsoniazidMycobacterium tuberculosis infectionIsoniazidSystemic lupus erythematosusIsoniazidTonsillitisIsoniazid非复杂性皮肤和皮肤结构感染IsoniazidPneumoniaIsoniazid
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ethambutol Hydrochloride/Rifampicin/Isoniazid | Tier C — Watch / trade | - |
| Isoniazid | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-Pyridinenitrile→Isonicotinamide
Ethambutol Hydrochloride/Rifampicin/IsoniazidOptimised routesteps: 2total yield: 125.2(Isoniazid (Free))
4-Pyridinenitrile→Isonicotinamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.